FDA.reportPublic FDA data

DOCUSATE SODIUM

Substance profile for UNII F05Q2T2JA0, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for DOCUSATE SODIUM
Structure render from PubChem CID 23673837

Substance Identity#

UNII
F05Q2T2JA0
Preferred term
DOCUSATE SODIUM
Registry number
577-11-7
EC number
209-406-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C20H37O7S.Na
Chemical structure for DOCUSATE SODIUM
Structure render from PubChem CID 23673837

Chemical And Database Identifiers#

SMILES
[Na+].CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S([O-])(=O)=O
RxCUI
71722
PubChem
23673837
NCIt
C29000
INN ID
531

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound23673837pubchem.ncbi.nlm.nih.gov/compound/23673837
RxNorm71722mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=71722
NCI ThesaurusC29000ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29000
FDA Substance Registration SystemF05Q2T2JA0precision.fda.gov/uniisearch/srs/unii/F05Q2T2JA0
European Community number209-406-4commonchemistry.cas.org/results?q=209-406-4

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTDrug Facts5
ACTIVE INGREDIENTDOCUSATE SODIUM AND SENNA2
INACTIVE INGREDIENTSULFAMETHOXAZOLE AND TRIMETHOPRIM3
ACTIVE INGREDIENTDoc2
ACTIVE INGREDIENTDrug Facts3
ACTIVE INGREDIENTDrug Facts3
ACTIVE INGREDIENTDrug Facts4
INACTIVE INGREDIENTAlprazolam Tablets, USP2
INACTIVE INGREDIENTAlprazolam Tablets, USP2
INACTIVE INGREDIENTALPRAZOLAM TABLETS, USP 0.25 mg, 0.5 mg, 1 mg and 2 mg2
INACTIVE INGREDIENTALPRAZOLAM5
ACTIVE INGREDIENTDOCUSATE SODIUM2
ACTIVE INGREDIENT1235366d-b572-3a41-e054-00144ff8d46c2
ACTIVE INGREDIENT1233853f-01b7-6305-e054-00144ff88e882
INACTIVE INGREDIENTALPRAZOLAM TABLETS, USP CIV Rx only2
ACTIVE INGREDIENTDrug Facts2
ACTIVE INGREDIENT0fbb189e-62f3-d9bb-cd48-d88e0648eb502
ACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENTALPRAZOLAM TABLETS, USP CIV2
INACTIVE INGREDIENTCitraNatal ® Rx1
ACTIVE INGREDIENTBLOAT RELEASE2
ACTIVE INGREDIENTfa8470fb-6e36-4c5a-8b44-cc9965638bb51
INACTIVE INGREDIENTHYDROCHLOROTHIAZIDE CAPSULES USP1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use TRICOR safely and effectively. See full prescribing information for TRICOR. TRICOR (fenofibrate) Tablet for oral use Initial U.S. Approval: 19932
ACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 19933
INACTIVE INGREDIENTSulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (Double Strength) and 400 mg/80 mg2
INACTIVE INGREDIENTAlprazolam Tablets, USP2
ACTIVE INGREDIENTE-Vac Plus1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Megace ES safely and effectively. See full prescribing information for Megace ES. Megace ES (megestrol acetate, USP) Oral Suspension Initial U.S. Approval: 1993 ® ® ®3
ACTIVE INGREDIENTDrug Facts1
ACTIVE INGREDIENTDocusate Sodium 250mg11
INACTIVE INGREDIENTThese highlights do not include all the information needed to use finasteride tablets USP safely and effectively. See full prescribing information for finasteride tablets USP. Finasteride Tablets USP Initial U.S. Approval: 19921
ACTIVE INGREDIENTDOCUSATE SOD SENNA 50 8 6MG FOR RUGBY1
INACTIVE INGREDIENTDESOXIMETASONE GEL USP, 0.05%2
INACTIVE INGREDIENTAlprazolam Tablets, USP CIV2
INACTIVE INGREDIENTALPRAZOLAM TABLETS, USP CIV Rx only1
ACTIVE INGREDIENTPromolaxin™ Docusate Sodium Stool Softener1
INACTIVE INGREDIENTCICLOPIROX GEL 0.77%6
INACTIVE INGREDIENTPrednisone Tablets USP Revised: September 2008 Rx only 1736661
ACTIVE INGREDIENTPeri-Colace Drug Facts1
ACTIVE INGREDIENTDrug Facts1
ACTIVE INGREDIENTSenexon-S Tablets6
INACTIVE INGREDIENTSohMed™ Allergy Sinus1
INACTIVE INGREDIENTSULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS USP2
ACTIVE INGREDIENTa8f7554c-eae7-44fb-ac66-a7d678bcb91a1
ACTIVE INGREDIENTUnknown Title2
ACTIVE INGREDIENTSenna and Docusate Sodium Film Coated Red Tablets 8.6 mg/ 50 mg Laxative5
ACTIVE INGREDIENTLaxacin Laxative Plus Stool Softener2
INACTIVE INGREDIENTCHLORZOXAZONE TABLETS, USP 500 mg Revised: November 2010 Rx only 1956093
ACTIVE INGREDIENTTrinatal Ultra Tablets2
INACTIVE INGREDIENTSulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (Double Strength) and 400 mg/80 mg3
ACTIVE INGREDIENTTL-Care DHA Softgels2
ACTIVE INGREDIENTDocusate Sodium, USP 100mg2
INACTIVE INGREDIENTInflam-X1
ACTIVE INGREDIENT4a91eee4-6808-45a6-9df1-274a6ad990b42
ACTIVE INGREDIENTSenna Plus8
ACTIVE INGREDIENTTL-Select DHA Softgel Capsules1
ACTIVE INGREDIENTRugby Extra Strength Stool Softener Laxative1000
ACTIVE INGREDIENTTL-Select Softgel Capsules2
ACTIVE INGREDIENTDrug Facts1
ACTIVE INGREDIENTDrug Facts2
INACTIVE INGREDIENTDOXYCYCLINE HYCLATE TABLETS, USP2
ACTIVE INGREDIENTNon-Habit Forming Stool Softener Laxative1
INACTIVE INGREDIENTGRISEOFULVIN ORAL SUSPENSION (microsize) USP, 125 mg/5 mL Rx Only1
INACTIVE INGREDIENT86d1eec6-fb4d-42da-86f4-16ecd9f6a0df6
INACTIVE INGREDIENTDOXYCYCLINE HYCLATE TABLETS, USP2
INACTIVE INGREDIENTDrug Facts3
INACTIVE INGREDIENTCHLORZOXAZONE TABLETS, USP 500 mg Revised: November 2010 Rx only 1956092
ACTIVE INGREDIENTDocusate Sodium ES1
INACTIVE INGREDIENTDrug Facts5
ACTIVE INGREDIENTSenna-S5
ACTIVE INGREDIENTDrug Facts2
ACTIVE INGREDIENT9e0d04b2-bef8-4adf-aee4-c0fd2d62c84f2
INACTIVE INGREDIENTAlprazolam Tablets, USP CIV1
INACTIVE INGREDIENTSULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS USP, 800 mg/160 mg1
INACTIVE INGREDIENTHYDROCHLOROTHIAZIDE CAPSULES USP3
ACTIVE INGREDIENTLeader Stool Softener plus Laxative2
INACTIVE INGREDIENTMinoxidil Tablets USP Revised: June 2009 Rx only 1907992
INACTIVE INGREDIENTHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use finasteride tablets USP safely and effectively. See full prescribing information for finasteride tablets USP. Finasteride Tablets USP Initial U.S. Approval: 1992 RX only7
INACTIVE INGREDIENTTARKA® (trandolapril/verapamil hydrochloride ER tablets)2
INACTIVE INGREDIENTThese highlights do not include all the information needed to use EPIDUO Gel safely and effectively. See full prescribing information for EPIDUO Gel. EPIDUO (adapalene and benzoyl peroxide) Gel 0.1%/2.5% For topical use Initial U.S. Approval: 20082
INACTIVE INGREDIENTThese highlights do not include all the information needed to use C arisoprodol Tablets USP safely and effectively. See full prescribing information for carisoprodol . C arisoprodol Tablets for Oral use Initial U.S. Approval: 19591
INACTIVE INGREDIENTCHLORZOXAZONE TABLETS, USP 500 mg Revised: November 2010 Rx only 1956093
INACTIVE INGREDIENTDOXYCYCLINE HYCLATE TABLETS, USP1
ACTIVE INGREDIENTNon-Habit Forming Stool Softener Laxative2
INACTIVE INGREDIENTDulcolax ®1
ACTIVE INGREDIENTDrug Facts2
ACTIVE INGREDIENTf6e923e8-46e8-4287-bd62-5b954829cd732
INACTIVE INGREDIENTAlprazolam Tablets, USP CIV2
INACTIVE INGREDIENTSulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (Double Strength) and 400 mg/80 mg1
ACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTCHLORZOXAZONE TABLETS, USP 500 mg Revised: November 2010 Rx only 1956091
ACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTGabazolamine13
INACTIVE INGREDIENTSentrazolam AM-0.259
INACTIVE INGREDIENTGabazolamine-0.58
INACTIVE INGREDIENTAlprazolam Tablets, USP CIV1
INACTIVE INGREDIENTAlprazolam Tablets4
INACTIVE INGREDIENTAlprazolam tablets5
ACTIVE INGREDIENTCitraNatal Harmony ® Rx Prenatal Vitamin Gel Cap1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Megace® ES safely and effectively. See full prescribing information for Megace® ES. Megace ES (megestrol acetate) Oral Suspension Initial U.S. Approval: 19931
INACTIVE INGREDIENTDOXYCYCLINE HYCLATE TABLETS, USP4
INACTIVE INGREDIENTRifampin Capsules, USP2
INACTIVE INGREDIENTTRIAZOLAM Tablets, USP 0.125 mg and 0.25 mg CIV2
INACTIVE INGREDIENTSulfamethoxazole and Trimethoprim Tablets, USP2
INACTIVE INGREDIENTb4cd760f-2ebd-4789-9e53-42141e3def1f1
INACTIVE INGREDIENTTRANZGEL HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL5
INACTIVE INGREDIENTTRANZGEL HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL2
INACTIVE INGREDIENTCHLORZOXAZONE TABLETS, USP 500 mg 05422
INACTIVE INGREDIENTHYDROCHLOROTHIAZIDE2
ACTIVE INGREDIENTTriCare® Prenatal DHA ONE® Softgel4
INACTIVE INGREDIENTFinasteride Tablets USP, 5 mg RX Only4
INACTIVE INGREDIENTdrug facts1
INACTIVE INGREDIENTdrug facts1
INACTIVE INGREDIENTTriazolam tablets, USP CIV1
INACTIVE INGREDIENTAlprazolam Tablets, USP CIV1000
ACTIVE INGREDIENTColace 50 mg1
INACTIVE INGREDIENTTRICOR® 48 mg and 145 mg (fenofibrate tablets)2
INACTIVE INGREDIENTETHAMBUTOL HYDROCHLORIDE TABLETS, USP3

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII F05Q2T2JA0 page 1 of 1 · 11 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
DOCUSATE SODIUMF05Q2T2JA0577117INJECTIONINTRAMUSCULAR0.02 %w/v
DOCUSATE SODIUMF05Q2T2JA0577117CAPSULEORAL8.2 mg
DOCUSATE SODIUMF05Q2T2JA0577117CAPSULE, EXTENDED RELEASEORALNA
DOCUSATE SODIUMF05Q2T2JA0577117GRANULE, FOR SUSPENSION, EXTENDED RELEASEORAL20 mg
DOCUSATE SODIUMF05Q2T2JA0577117SUSPENSIONORAL48 mg
DOCUSATE SODIUMF05Q2T2JA0577117SUSPENSION, EXTENDED RELEASEORAL0.77 mg
DOCUSATE SODIUMF05Q2T2JA0577117TABLETORAL50 mg
DOCUSATE SODIUMF05Q2T2JA0577117TABLET, COATEDORAL1 mg
DOCUSATE SODIUMF05Q2T2JA0577117TABLET, FILM COATEDORAL6 mg
DOCUSATE SODIUMF05Q2T2JA0577117GELTOPICAL6 mg
DOCUSATE SODIUMF05Q2T2JA0577117SHAMPOOTOPICAL2 %w/w